SYNERGISTIC ANTICELLULAR AND ANTIVIRAL ACTIVITIES OF HUMAN RECOMBINANT INTERFERON-γ AND -β
スポンサーリンク
概要
- 論文の詳細を見る
The synergism of anticellular and antiviral activities of recombinant human interferon-γ (ReIFN-γ) and recombinant human interferon-β (ReIFN-β) was examined in vitro using human melanoma SK-MEL-28 cells. Some differences were detected in the kinetics of anticellular activity between both IFNs, namely the inhibitory effect of ReIFN-β occurred earlier than that of ReIFN-γ. Significant synergism was detected in the anticellular activity of both IFNs when growth curves and isobolograms were examined. A difference between ReIFN-γ and ReIFN-β was also detected in activiral activity. The antiviral activity of ReIFN-γ against vesicular stomatitis virus (VSV) was significantly weaker than that of ReIFN-β, even though both IFNs exhibited almost equivalent antiviral activities against Sindbis virus. However, ReIFN-γ and ReIFN-β exhibited synergistic antiviral activities against both VSV and Sindbis virus. The analysis of cell cycle distribution by flow cytometry revealed that there were some differences in the distribution pattern between cells treated with ReIFN-γ alone, ReIFN-β alone, or ReIFN-γ and ReIFN-β in combination. ReIFN-β induced a prolongation or accumulation of S phase, whereas the effect of ReIFN-γ was cycle-nonspecific. The combination of ReIFN-γ and ReIFN-β induced a decrease of G_1 phase and an increase of G_2M phase. These results suggest that ReIFN-γ and ReIFN-β used in combination were more effective in inhibiting the growth of human tumor cells and the proliferation of viruses than IFN used individually.
- 公益社団法人日本薬学会の論文
著者
-
GOMI Katsushige
Pharmaceutical Research Institute, Kyowa Hakko Kogyo Company, Ltd.,
-
Oka T
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
OKA TETSUO
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
MORIMOTO MAKOTO
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
-
KIMURA HIROKO
Pharmaceuticals Research Laboratory, Kyowa Hakko Kogyo Co., Ltd.
-
OKABE MASAMI
Pharmaceuticals Research Laboratory, Kyowa Hakko Kogyo Co., Ltd.
-
Okabe M
Pharmaceuticals Research Laboratory Kyowa Hakko Kogyo Co. Ltd.
-
Okabe Masami
Pharmaceuticals Research Laboratory Kyowa Hakko Kogyo Co. Ltd.
-
Kimura Hiroko
Pharmaceuticals Research Laboratory Kyowa Hakko Kogyo Co. Ltd.
-
Morimoto M
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Gomi Katsushige
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Gomi Katsushige
Pharmaceutical Research Institute Kyowa Hakko Kogyo Company Ltd.
関連論文
- Synthesis and Antitumor Activity of Duocarmycin Derivatives : A-Ring Pyrrole Compounds Bearing 5-Membered Heteroarylacryloyl Groups
- Synthesis and Antitumor Activity of Duocarmycin Derivatives : Modification of Segment A of Duocarmycin B2
- Wagner-Meerwein Rearrangement of Duocarmycins
- Hyperlipemia and Early Pancreatic Injury Induced by Ethanol Intake in Rats
- Effect of Nd422 Addition on Jc in Nd123 Melt-Textured Bulk Superconductor
- Pulsed Field Magnetization of Melt-Processed Y-Ba-Cu-O Bulk Superconductor with No Weak Links
- High-Temperature Superconducting Motor Using Y-Ba-Cu-O Bulk Magnets
- Metallurgical Reactions and Their Relationships to Enhanced Mechanical Strength in Zr-Bearing YBCO Composite Superconductors
- Mechanical and Superconducting Properties of Ag/YBCO Composite Superconductors Reinforced by the Addition of Zr
- CHARACTERIZATION OF RECEPTORS FOR HUMAN RECOMBINANT INTERFERON-γ IN HUMAN CELLS
- ANTITUMOR EFFECT OF HUMAN RECOMBINANT INTERFERON-γ AND -β AGAINST HUMAN OSTEOSARCOMA TRANSPLANTED INTO NUDE MICE
- SYNERGISTIC ANTICELLULAR AND ANTIVIRAL ACTIVITIES OF HUMAN RECOMBINANT INTERFERON-γ AND -β
- CHEMO-IMMUNOTHERAPY OF METHYLCHORANTHRENE-INDUCED FIBROSARCOMA BY CONCANAVALIN A-BOUND TUMOR VACCINE, LEVAMISOLE AND MITOMYCIN C
- ANTITUMOR EFFECT OF HUMAN RECOMBINANT INTERFERON-β AGAINST HUMAN MELANOMAS TRANSPLANTED INTO NUDE MICE